EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.4100
-0.0050 (-1.20%)
Sep 18, 2026, 11:52 AM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 19.53 million as of September 17, 2026. Its market cap has decreased by -81.43% in one year.
Market Cap
19.53M
Enterprise Value
10.29M
Revenue
46.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
ChartMarket Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 19.53M, a decrease of -59.91%. That is a compound annual growth rate of -15.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 19.53M | -70.55% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 25.33M |
| Proteomics International Laboratories | 23.15M |
| Imugene | 23.02M |
| Patrys | 22.94M |
| Noxopharm | 20.58M |
| Argenica Therapeutics | 19.27M |
| Algorae Pharmaceuticals | 18.25M |
| Neurotech International | 16.53M |